Bloodstream infections and sepsis in Greece: Over-time change of epidemiology and impact of de-escalation on final outcome

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Koupetori, Marina ^a   Retsas, Theodoros ^b   Antonakos, Nikolaos ^b   Vlachogiannis, Glykeria ^c   Perdios, Ioannis ^d   Nathanail, Christos ^e   Makaritsis, Konstantinos ^f   Papadopoulos, Antonios ^b   Sinapidis, Dimitrios ^b   Giamarellos Bourboulis, Evangelos J ^b   Pneumatikos, Ioannis ^g   Gogos, Charalambos ^h   Armaganidis, Apostolos ^b   Paramythiotou, Elisabeth ^b  

^a THRIASIO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c General Hospital of Thessaloniki 'O Aghios Dimitrios   (Greece)

^d Artas General Hospital   (Greece)

^e GENERAL HOSPITAL OF LARISSA   (Greece)

^f G GENNIMATAS GENERAL HOSPITAL   (Greece)

^g Intensive Care Unit Democriteion University Hospital   (Greece)

^h UNIVERSITY OF PATRAS   (Greece)

Author keywords

Bloodstream infections; De escalation; Resistance; Sepsis

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; DEESCALATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG USE; FEMALE; GRAM NEGATIVE BACTERIUM; GREECE; HEALTH CARE FACILITY; HEMOFILTRATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; RISK FACTOR; SEPSIS; WARD; BACTEREMIA; CLINICAL TRIAL; EPIDEMIOLOGY; LONG TERM CARE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GREECE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LONG-TERM CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS;

EID: 84901602158     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-272     Document Type: Article

References (23)

1. Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res 2005, 36:646-659. 10.1016/j.arcmed.2005.02.005, 16216646.
2. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003, 41:3655-3660. 10.1128/JCM.41.8.3655-3660.2003, 179863, 12904371.
3. Chen HC, Lin WL, Lin CC, Hsieh WH, Hsieh CH, Wu MH, Wu JY, Le CC. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 2013, 68:947-953. 10.1093/jac/dks475, 23264512.
4. Retamar P, Portillo MM, Lopez-Prieto MD, Rodríguez-López F, De Cueto M, García MV, Gómez MJ, Del Arco A, Muñoz A, Sánchez-Porto A, Torres-Tortosa M, Martín-Aspas A, Arroyo A, García-Figueras C, Acosta F, Corzo JE, León-Ruiz L, Escobar-Lara T, Rodríguez-Baño J. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 2012, 56:472-478. 10.1128/AAC.00462-11, 3256027, 22005999.
5. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005, 49:760-766. 10.1128/AAC.49.2.760-766.2005, 547233, 15673761.
6. Morata L, Cobos-Trigueros N, Martínez JA, Martínez JA, Soriano A, Almela M, Marco F, Sterzik H, Núňez R, Hernández C, Mensa J. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2012, 56:4833-4837. 10.1128/AAC.00750-12, 3421866, 22751533.
7. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941.
8. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002, 122:2183-2196. 10.1378/chest.122.6.2183, 12475862.
9. Niederman MS. The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 2006, 27:45-50. 10.1055/s-2006-933673, 16508881.
10. Niederman MS, Soulountsi V. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?. Clin Chest Med 2011, 32:517-534. 10.1016/j.ccm.2011.05.009, 21867820.
11. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008, 13:47.
12. Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opsal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2001, 2003(31):1250-1256.
13. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15:148-151. 10.1016/S0735-6757(97)90087-5, 9115515.
14. Giamarellos-Bourboulis EJ, Pechère JC, Routsi C, Plachouras D, Kollias S, Raftogiannis M, Zervakis D, Baziaka F, Koronaios A, Antonopoulou A, Markaki V, Koutoukas P, Papadomichelakis E, Tsaganos T, Armaganidis A, Koussoulas V, Kotanidou A, Roussos C, Giamarellou H. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008, 46:1157-1164. 10.1086/529439, 18444850.
15. Calandra T, Cohen J. The International Sepsis Forum Consensus definitions of infections in the intensive care unit. Crit Care Med 2005, 33:1639-1648.
16. Valles J, Palomar M, Alvárez-Lerma F, Rello J, Blanco A, Garnacho-Montero J, Martin-Loeches I. Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia. Crit Care Med 2013, 41:76-83. 10.1097/CCM.0b013e3182676698, 23222266.
17. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329. 10.1001/jama.2009.1754, 19952319.
18. Rodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E, Herrero M, Del Arco A, Muñoz A, Téllez F, Torres-Tortosa M, Martín-Aspas A, Arroyo A, Ruiz A, Moya R, Corzo JE, León L, Pérez-López JA. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 2010, 16:1408-1413. 10.1111/j.1469-0691.2010.03089.x, 19845694.
19. Ammerlaan HS, Harbarth S, Buiting AG, Crook DW, Fitzpatrick F, Hanberger H, Herwalt LS, van Keulen PH, Kluytmans JA, Kola A, Kuckenbecker RS, Lingaas E, Meessen N, Morris-Downes MM, Pottinger JM, Rohner P, dos Santos RP, Seifert H, Wisplinghoff H, Ziesing S, Walker AS, Bonten MJ. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis 2013, 56:798-805. 10.1093/cid/cis1006, 23223600.
20. Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010, 50:364-373. 10.1086/649865, 20041768.
21. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
22. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Márquez-Vácaro JA. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014, 40:32-40. 10.1007/s00134-013-3077-7, 24026297.
23. Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004, 30:580-588.